This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Q2 FY27 revenue rises 94.7% as EBITDA margin contracts
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the quarter ended September 30, 2026 showed revenue from operations of Rs 6,399.46 lakh, up 94.7% from Rs 3,285.99 lakh a year earlier, while profit after tax was nearly flat at Rs 154.37 lakh versus Rs 153.92 lakh. EBITDA margin fell to 4.93% from 8.23%, a 3.30 percentage-point decline. Standalone half-year revenue rose 53.0% to Rs 10,107.70 lakh, but profit after tax fell 16.3% to Rs 299.07 lakh.
Revenue growth is positive, but a 3.30 percentage-point EBITDA margin decline and nearly flat quarterly PAT may limit near-term stock upside.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹63.99 Cr | ₹32.86 Cr | +94.7% |
| Operating profit | ₹1.26 Cr | ₹0.51 Cr | +145.1% |
| Profit after tax | ₹1.54 Cr | ₹1.54 Cr | +0.3% |
| EBITDA margin | 4.9% | 8.2% | −3.3 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.